p53 polymorphism and risk of cervical cancer [9]

Lancet

Volumn 352, Issue 9140, 1998, Pages 1631-

  Lanham, S ^a   Campbell, I ^a   Watt, P ^a   Gornall, R ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; LETTER; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0032517478     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61083-5     Document Type: Letter

References (2)

1. A Storey M Thomas A Kalita Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 1998 229 234
2. AN Rosenthal A Ryan RM Al-Jehani A Storey CA Harwood IJ Jacobs p53 codon 72 polymorphism and risk of cervical cancer in UK Lancet 352 1998 871 875